Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: billkirn who wrote (3196)	12/7/1997 10:53:00 PM
From: Izzy	Read Replies (1) of 6136

Bill (and Peter and Paul, etc.): Talk about a double standard. If you have time, read VRTX post #108. I actually don't get it (re: VRTX posters) because I really like both AGPH and VRTX. However, I only have AGPH stock now because of its superb PI (Viracept) that allows me to appropriately treat HIV+ patients with the best available PI, IMO. VRTX just doesn't have anything (yet) and the findings of the stage III clinical trials won't be out for months. But, I don't wish to bash VRTX or any other company that is trying to develop an effective HIV treatment.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next